Cargando…
Differential Fibrinolysis Profile in COVID-19 Patients Dependent on Immunosuppressive Treatment Regimen: A Nested Case-Control Study
Autores principales: | Nagy, Magdolna, Schellens, Joep, Hulshof, Anne-Marije, van Rosmalen, Frank, van Oerle, Rene, van Herpt, Thijs T.W., Alnima, Teba, Mulder, Mark, Hellenbrand, Dave, ten Cate, Hugo, Henskens, Yvonne M.C., Van Bussel, Bas C.T., Spronk, Henri M.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665185/ http://dx.doi.org/10.1182/blood-2022-162283 |
Ejemplares similares
-
COVID-19 Coagulopathy: From Pathogenesis to Treatment
por: Alnima, Teba, et al.
Publicado: (2022) -
Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability
por: van de Berg, Tom W., et al.
Publicado: (2021) -
Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID Cohort
por: van de Berg, Tom W., et al.
Publicado: (2022) -
Hemostasis and fibrinolysis in COVID‐19 survivors 6 months after intensive care unit discharge
por: Hulshof, Anne‐Marije, et al.
Publicado: (2021) -
Thrombin Generation Capacity of Prothrombin Complex Concentrate in an In Vitro Dilutional Model
por: Grottke, Oliver, et al.
Publicado: (2013)